Sheng Lin-Gibson is the chief of the Biosystems and Biomaterials Division at the National Institute of Standards and Technology (NIST). She oversees a multidisciplinary research portfolio that includes advanced therapies, precision medicine, synthetic biology and complex microbial systems. She leads and coordinates the development of global standards for emerging biotechnology.